+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Takeda Pharmaceutical Company Limited - logo

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

From
Diabetes Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Diabetes Drugs Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
From
From
General Anxiety Disorder (GAD) - Pipeline Insight, 2025 - Product Thumbnail Image

General Anxiety Disorder (GAD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
From
Liver Fibrosis Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Liver Fibrosis Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 196 Pages
  • Global
From
From
From
Immunotoxins - Global Strategic Business Report - Product Thumbnail Image

Immunotoxins - Global Strategic Business Report

  • Report
  • April 2026
  • 377 Pages
  • Global
From
Angiotensin Receptor Blockers (ARBs) Market Report 2026 - Product Thumbnail Image

Angiotensin Receptor Blockers (ARBs) Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Pharmerging - Global Strategic Business Report - Product Thumbnail Image

Pharmerging - Global Strategic Business Report

  • Report
  • April 2026
  • 184 Pages
  • Global
From
From
Nephrology Drugs Market Report 2026 - Product Thumbnail Image

Nephrology Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Focal Segmental Glomerulosclerosis Drugs Market Report 2026 - Product Thumbnail Image

Focal Segmental Glomerulosclerosis Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Market Report 2026 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator